Here are the S-3 shelf registrations from 4D Molecular Therapeutics, Inc. (FDMT) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
An S-3 covers the shelf registration that lets an established company sell over time, so if you follow FDMT and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full FDMT filings page.
4D Molecular Therapeutics, Inc. files a shelf registration to register up to $400.0 million of securities, which includes $200.0 million of unsold securities previously registered and approximately $200.0 million of additional securities.
The prospectus covers multiple classes — common stock, preferred stock, debt securities, warrants and units — to be sold from time to time under a shelf process. The document is a preliminary prospectus dated May 7, 2026 and states that specific offering terms will be provided in prospectus supplements.